Clinical study of butenafine hydrochloride 1% cream in the treatment of tinea pedis, tinea corporis and tineacruris

Journal of Clinical Dermatology

Volumn 35, Issue 7, 2006, Pages 471-472

  Li, Min ^a   Bi, Zhi Gang ^a   Gu, Jun ^a   Sheng, Yong Nian ^a   Zhang, Mei Huan ^a   Wang, Ying ^a   Liu, Wei Da ^a  

^a INSTITUTE OF DERMATOLOGY   (China)

Author keywords

Butenafine hydrochloride; Tinea corporis; Tinea cruris; Tinea pedis

Indexed keywords

BUTENAFINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREAM; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; TINEA CORPORIS; TINEA CRURIS; TINEA PEDIS; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

EID: 33748324602     PISSN: 10004963     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Reyes BA, Beutner KR, Cullen SI, et al. Butenafine, a fungicidal benzylamine derivative, used once daily for the treatment of interdigital tinea pedis[J]. Int J Dermatol, 1998, 37(6): 450-453.
2. Greer DL, Weiss J, Rodriguez DA, et al. A randomized trial to assess once-daily topical treatment of tinea corporis with butenafine, a new antifungal agent[J]. J Am Acad Dermatol, 1997, 37(2 Pt 1): 231-235.
3. Lesher JL Jr, Babel DE, Stewart DM, et al. Butenafine 1% cream in the treatment of tinea cruris: a multicenter, vehicle-controlled, double-blind trial[J]. J Am Acad Dermatol, 1997, 36 (2 Pt 1): S20-S24.
4. Savin R, De Villez RL, Elewski B, et al. One-week therapy with twice-daily butenafine 1% cream versus vehicle in the treatment of tinea pedis: a multicenter, double-blind trial[J]. J Am Acad Dermatol, 1997, 36(2 Pt 1): S15-S19.
5. Tschen E, Elewski B, Gorsulowsky DC, et al. Treatment of interdigital tinea pedis with a 4-week once-daily regimen of butenafine hydrochloride 1% cream[J]. J Am Acad Dermatol, 1997, 36(2 Pt 1): S9-S14.
6. Shelley WB, Shelley ED. Advanced Dermatologic Therapy I [M]. Philadelphia: Saunders, 2001: 497-513.
7. Chinese source. 2003, 32(2): 111-112.
8. Chinese source. 2001, 17(5): 344-347.